Intacept 25mg Injection

Intacept 25mg Injection is an immunosuppressant medicine that helps reduce signs and symptoms of autoimmune disorders. It is primarily used in the treatment of rheumatoid arthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, and plaque psoriasis. Intacept 25mg Injection is generally used alone or in combination with methotrexate medicine. Intacept 25mg Injection consists of Etanercept, which belongs to the TNF (Tumor necrosis factor) inhibitor class of drugs. It works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation and pain caused due to various autoimmune diseases.

Intacept 25mg Injection can be administered via subcutaneous injection and intravenous infusion. The choice of administration route depends on the patient's condition, preferences, and the healthcare provider's recommendation, both of which have been proven effective in treating autoimmune diseases.

Intacept 25mg Injection's mechanism of action involves its role as a tumor necrosis factor (TNF) inhibitor. By binding to circulating TNF-alpha and acting as a decoy receptor, this medication disrupts the inflammatory signaling pathway, suppressing immune cell activation and reducing the production of inflammatory cytokines. This neutralization of TNF-alpha effectively mitigates inflammation, making it highly effective.

COLD CHAIN

1 PFS